[Bacterial DNA in patients with cirrhosis and sterile ascites. Its role as a marker of bacterial translocation and prognostic tool]
- PMID: 18052664
- DOI: 10.4321/s1130-01082007001000007
[Bacterial DNA in patients with cirrhosis and sterile ascites. Its role as a marker of bacterial translocation and prognostic tool]
Abstract
During the last decade, we have witnessed an increase in the amount of data related with the presence of bacterial translocation in experimental models of cirrhosis. However, clinical studies have been limited by the lack of non-invasive methods to study this phenomenon. Over the past years, the research developed in our laboratory has been focused on the detection of bacterial DNA in serum and ascitic fluid of patients with cirrhosis and sterile ascites, the clinical and immunological implications of such finding. Initially, by means of a polymerase chain reaction (PCR)-based method and automated nucleotide sequencing, we were able to detect and identify the presence of fragments of bacterial DNA in the mentioned patients with culture-negative, non-neutrocytic ascites. Since then, we have accumulated a core of data suggesting that the presence of bacterial DNA may have an important role not only as a marker of bacterial translocation, but also as a short-term prognostic factor. Here, we discuss the past, present and future of this line of investigation.
Similar articles
-
Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites.Hepatology. 2002 Jul;36(1):135-41. doi: 10.1053/jhep.2002.33715. Hepatology. 2002. PMID: 12085357
-
Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction.Liver Int. 2009 Sep;29(8):1206-14. doi: 10.1111/j.1478-3231.2009.02073.x. Epub 2009 Jul 7. Liver Int. 2009. PMID: 19602138
-
Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites.Liver Int. 2011 Apr;31(4):494-8. doi: 10.1111/j.1478-3231.2011.02448.x. Epub 2011 Jan 30. Liver Int. 2011. PMID: 21382159
-
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.Liver Int. 2013 Jan;33(1):31-9. doi: 10.1111/liv.12021. Epub 2012 Nov 4. Liver Int. 2013. PMID: 23121656 Review.
-
Markers of immunity and bacterial translocation in cirrhosis.Dan Med J. 2015 Jul;62(7):B5121. Dan Med J. 2015. PMID: 26183053 Review.
Cited by
-
Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.Am J Gastroenterol. 2015 Oct;110(10):1399-410; quiz 1411. doi: 10.1038/ajg.2015.313. Epub 2015 Sep 29. Am J Gastroenterol. 2015. PMID: 26416191 Review.
-
Escherichia/Shigella, SCFAs, and Metabolic Pathways-The Triad That Orchestrates Intestinal Dysbiosis in Patients with Decompensated Alcoholic Cirrhosis from Western Mexico.Microorganisms. 2022 Jun 16;10(6):1231. doi: 10.3390/microorganisms10061231. Microorganisms. 2022. PMID: 35744749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous